Figure 5

Comorbidities and intracellular YB-1acetyl content. (A) Diagram showing the distribution of YB-1acetyl following LPS in dialysis patients and healthy controls. Most dialysis patients suffering from diabetes (red bar graphs) react with an increase of intracellular YB-1acetyl following LPS incubation. (B) Scatter plots showing the distribution of monocyte sub-populations Mo1-Mo3 following LPS incubation in dialysis patients without and with diabetes. (level of significance: *p < 0.05; **p < 0.005).